Cargando…
Immune suppression in the early stage of COVID-19 disease
The outbreak of COVID-19 has become a worldwide pandemic. The pathogenesis of this infectious disease and how it differs from other drivers of pneumonia is unclear. Here we analyze urine samples from COVID-19 infection cases, healthy donors and non-COVID-19 pneumonia cases using quantitative proteom...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673112/ https://www.ncbi.nlm.nih.gov/pubmed/33203833 http://dx.doi.org/10.1038/s41467-020-19706-9 |
_version_ | 1783611268564779008 |
---|---|
author | Tian, Wenmin Zhang, Nan Jin, Ronghua Feng, Yingmei Wang, Siyuan Gao, Shuaixin Gao, Ruqin Wu, Guizhen Tian, Di Tan, Wenjie Chen, Yang Gao, George Fu Wong, Catherine C. L. |
author_facet | Tian, Wenmin Zhang, Nan Jin, Ronghua Feng, Yingmei Wang, Siyuan Gao, Shuaixin Gao, Ruqin Wu, Guizhen Tian, Di Tan, Wenjie Chen, Yang Gao, George Fu Wong, Catherine C. L. |
author_sort | Tian, Wenmin |
collection | PubMed |
description | The outbreak of COVID-19 has become a worldwide pandemic. The pathogenesis of this infectious disease and how it differs from other drivers of pneumonia is unclear. Here we analyze urine samples from COVID-19 infection cases, healthy donors and non-COVID-19 pneumonia cases using quantitative proteomics. The molecular changes suggest that immunosuppression and tight junction impairment occur in the early stage of COVID-19 infection. Further subgrouping of COVID-19 patients into moderate and severe types shows that an activated immune response emerges in severely affected patients. We propose a two-stage mechanism of pathogenesis for this unusual viral infection. Our data advance our understanding of the clinical features of COVID-19 infections and provide a resource for future mechanistic and therapeutics studies. |
format | Online Article Text |
id | pubmed-7673112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-76731122020-11-24 Immune suppression in the early stage of COVID-19 disease Tian, Wenmin Zhang, Nan Jin, Ronghua Feng, Yingmei Wang, Siyuan Gao, Shuaixin Gao, Ruqin Wu, Guizhen Tian, Di Tan, Wenjie Chen, Yang Gao, George Fu Wong, Catherine C. L. Nat Commun Article The outbreak of COVID-19 has become a worldwide pandemic. The pathogenesis of this infectious disease and how it differs from other drivers of pneumonia is unclear. Here we analyze urine samples from COVID-19 infection cases, healthy donors and non-COVID-19 pneumonia cases using quantitative proteomics. The molecular changes suggest that immunosuppression and tight junction impairment occur in the early stage of COVID-19 infection. Further subgrouping of COVID-19 patients into moderate and severe types shows that an activated immune response emerges in severely affected patients. We propose a two-stage mechanism of pathogenesis for this unusual viral infection. Our data advance our understanding of the clinical features of COVID-19 infections and provide a resource for future mechanistic and therapeutics studies. Nature Publishing Group UK 2020-11-17 /pmc/articles/PMC7673112/ /pubmed/33203833 http://dx.doi.org/10.1038/s41467-020-19706-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Tian, Wenmin Zhang, Nan Jin, Ronghua Feng, Yingmei Wang, Siyuan Gao, Shuaixin Gao, Ruqin Wu, Guizhen Tian, Di Tan, Wenjie Chen, Yang Gao, George Fu Wong, Catherine C. L. Immune suppression in the early stage of COVID-19 disease |
title | Immune suppression in the early stage of COVID-19 disease |
title_full | Immune suppression in the early stage of COVID-19 disease |
title_fullStr | Immune suppression in the early stage of COVID-19 disease |
title_full_unstemmed | Immune suppression in the early stage of COVID-19 disease |
title_short | Immune suppression in the early stage of COVID-19 disease |
title_sort | immune suppression in the early stage of covid-19 disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673112/ https://www.ncbi.nlm.nih.gov/pubmed/33203833 http://dx.doi.org/10.1038/s41467-020-19706-9 |
work_keys_str_mv | AT tianwenmin immunesuppressionintheearlystageofcovid19disease AT zhangnan immunesuppressionintheearlystageofcovid19disease AT jinronghua immunesuppressionintheearlystageofcovid19disease AT fengyingmei immunesuppressionintheearlystageofcovid19disease AT wangsiyuan immunesuppressionintheearlystageofcovid19disease AT gaoshuaixin immunesuppressionintheearlystageofcovid19disease AT gaoruqin immunesuppressionintheearlystageofcovid19disease AT wuguizhen immunesuppressionintheearlystageofcovid19disease AT tiandi immunesuppressionintheearlystageofcovid19disease AT tanwenjie immunesuppressionintheearlystageofcovid19disease AT chenyang immunesuppressionintheearlystageofcovid19disease AT gaogeorgefu immunesuppressionintheearlystageofcovid19disease AT wongcatherinecl immunesuppressionintheearlystageofcovid19disease |